Skip to main content
. 2015 Jun 23;19(9):2273–2285. doi: 10.1111/jcmm.12619

Figure 1.

Figure 1

Increased APLNR level in mice and human kidney. (A) Immunostating of APLNR in mice kidney. (B) The APLNR levels in the kidney of type 2 diabetic mice (kk-Ay mice) was significantly increased by 2.7-fold compared with that of control mice (C57BL). The data are expressed as the means ± SD (n = 6, *p < 0.01 versus control group). (C) APLNR level in the kidney of type 2 diabetic patients was significantly increased by 1.9-fold compared with that of control patients. The data are expressed as the means ± SD (n = 6, *p < 0.01 versus control group).